Identification of the components of protective immunity are crucial for the development of effective prophylactic and therapeutic vaccine strategies. Analysis of HIV-specific responses in exposed but uninfected individuals might thus provide a unique resource to elucidate the components and correlates of protective immunity to HIV. In the present study we analyzed HIV-specific cytotoxic and helper T lymphocyte responses in health care workers (HCW) exposed to body fluids from HIV-positive individuals. HCW exposed to blood from HIV-negative individuals as well as healthy donors served as controls. Cytotoxic T lymphocyte (CTL) responses to HlIV envelope (env) peptides were detected in 7/20 (35%) HCW exposed to HIV-positive blood and in none of the 20 health care workers exposed to uninfected blood or the seven healthy blood donors studied. HIV-specific CTL responses were detected only after in vitro stimulation, and were MHC class I restricted. No MHC class I restriction elements were uniformly identified among the different responders. 21/28 (75%) HCW exposed to contaminated blood responded to env as measured by IL-2 production to the peptides, in contrast to only 9/38 (24%) HCW exposed to HIV seronegative blood and 3/35 (9%) healthy blood donors. All the HIV exposed individuals were seronegative on repeated ELISA tests, and no evidence of infection was obtained by PCR analysis. These findings indicate that a single exposure to HIV can induce CTL immunity to HIV antigens, in the absence of other evidence of infection. (J. Clin. Invest. 1995. 96:867-876.)
Introduction
A better understanding of the reason that some individuals remain uninfected despite exposure to HIV is critically important for an understanding of the mechanisms of protective immunity and therefore for the development of more effective prophylac-tic and therapeutical vaccine strategies. T lymphocyte immunity may play an important role in the host's response to HIV infection. T cell immunity appears to be transient and declines simultaneously with other immune functions in the HIV-infected host as disease progresses (1) (2) (3) . Several lines of evidence suggest that cytotoxic T lymphocyte (CTL)' activities might be involved in delaying the onset of disease in HIV-infected patients (4) (5) (6) . Large numbers of circulating CTL and CTL precursor cells are present in asymptomatic HIV-infected (HIV +) individuals. Circulating CTL numbers decrease gradually with time, such that HIV-specific CTL become undetectable before major clinical deterioration (7, 8) . A balance between T cell responses and HIV titers appears to occur during latent infection and AIDS. Evidence for CD8+ cytotoxic T lymphocyte precursors specific for cells expressing HIV-1 gag, poi, and env with clearance of viremia in acute infection suggests that cellular immunity is involved in the initial control of virus replication in primary HIV infection and imply a role for CTL in protective immunity to HIV in vivo (9, 10) . Further evidence for a role of CTL activity in the delay of disease progression has been provided in studies on animal models of SIV and HIV infection (11, 12) .
Several lines of evidence suggest that exposure to HIV does not necessarily result in seroconversion or infection defined by standard criteria. Nevertheless, several laboratories have recently reported that exposure to HIV, in the absence of seroconversion, can induce HIV-specific cell mediated immune responses that have been suggested to contribute to virus clearance (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Accumulating evidence suggests that a rapid and effective CTL response during an invasive exposure to HIV might be involved in clearing the organism of the first infected cells. Unusually high frequencies of HIV-specific CTL precursors have been demonstrated also in uninfected donors, presumably related to priming by cross-reactive antigens such as homologous bacterial and viral proteins, HLA antigens and other self proteins as well as endogenous retroviral proteins (4) . It is plausible that rapid recruitment and expansion of these cells after limited HIV exposure could account for the protection against HIV infection. In this context, strong HIV specific CTL activity has been recently reported in uninfected infants born from HIV-infected mothers (17, 19, 20) . Furthermore, high frequency of CTL precursors against nef antigen was recently demonstrated in uninfected individuals sexually exposed to HIV (23).
We recently reported T helper cell reactivity to HIV envelope peptides in six out of eight health care workers (HCW) The Journal of Clinical Investigation, Inc. Volume 96, August 1995, 867-876 exposed to body fluids from HIV + patients (22) , as well as in PCR negative homosexual men who engage in high-risk sexual behavior (16) . However, T helper cell responses could be caused by exposure to defective or dead virus, whereas CD8 + CTL would be strongly suggestive that virus actually infected some cells to be presented with class I MHC molecules. HCW accidentally exposed to HIV represent a unique population for whom the time and type of exposure are specifically recorded. Furthermore, in contrast to other cohorts of HIV-exposed individuals, exposure of HCW should be lower and involve a single event. Although the risk of transmission of HIV in this population is estimated to be low (< 0.3%) (24) , it has been demonstrated that HIV can be readily cultured from the infected resid 
Synthetic peptides
The peptides used in this study were synthesized as previously described (25) (26) (27) (28) . Synthetic peptides corresponding to the env of HIV-1 (25) (26) (27) were used as previously described at 2.5 MM (28, 29 target incubated with 5% Triton X-100. After 6 h of incubation, supernatants were harvested and counted in a gamma counter (Micromedic Systems Inc., Horsham, PA). Percent specific lysis was determined as 100% X (test cpm-spontaneous cpm)/(maximum cpm-spontaneous cpm). A CTL response was considered positive when the difference between the percent lysis of peptide pulsed targets and percent lysis of RPMI-pulsed targets was > 15%. In cases of high percent lysis against RPMI-pulsed targets, responses were considered positive when the percent specific lysis against peptide-pulsed targets was three fold above the RPMI-pulsed targets. Antibody-blocking experiments were performed by incubating target cells with an anti-class I antibody W6/32 (anti-HLA-A,-B,-C) at a fixed E:T.
Generation of HIV-specific CD8+ cell lines CD8+ cells were isolated using Dynabeads (Dynal Inc., Lake Success, NY) according manufacturer's instructions. 1 x 106 cells were cultured in the presence of irradiated peptide-pulsed autologous PBMC (1.5
x 106 cells/well) in 48-well plates in media supplemented with 10% human serum. Interleukin-2 (10 U/ml; Boehringer Mannheim, Indianapolis, IN) was added 3 d after culture. The cells were restimulated weekly with irradiated autologous peptide-pulsed PBMC and maintained in IL-2 (10 U/ml) containing media, that was changed at 3-d intervals. CTL assays were performed as described above after four rounds of stimulation.
HIV-J provirus detection by PCR
PCR was performed according to the manufacturer's instructions (Roche Molecular Systems). Briefly, an ethylenediaminotetracetic acid-anticoagulated blood sample (0.5 ml) was processed with specimen wash reagent to lyse the blood red blood cells. The cell pellet was extracted with proteinase K and non-ionic detergents and amplified with SK431 / 462 primers (31) . To prevent carry over in this system uracil-N-glycosylase was utilized in the amplification mixture. Amplified product was detected by enzyme immunoassay using the SK102 probe.
Haplotype determination HLA antigens were determined by the tissue typing laboratory at Maryland Medical Laboratories (Baltimore, MD), using standard serologic assays.
HIV antibody
HIV antibody was measured with a commercial solid phase enzyme immunoassay (ELISA; Abbot Diagnostic, Abbot Park, IL).
Results
HIV specific cytotoxic T lymphocyte responses. Env-specific CTL responses were evaluated in 20 HIV-seronegative, PCR negative HCW with exposure to HIV contaminated blood/body fluids, as well as in 20 health care workers with exposure to seronegative blood and seven healthy blood donors, presumably unexposed to HIV. To induce expansion of HIV-specific primed T cells, PBMC were stimulated in vitro with each of the five individual peptides or a pool of peptides for 7 d. After this stimulation, bulk cultures of PBMC were assayed for cytotoxic activity against HIV env peptide pulsed-EBV transformed autologous B lymphoblastoid cell lines in a 6-h-51Cr-release assay. Seven of 20 individuals with known HIV exposure exhibited cytolytic activity against the peptide-pulsed targets at least once during the study (Fig. 1) . HIV-specific lysis was observed only in peptide-stimulated cultures and was not detected in fresh blood tested for CTL activity. Donor 1 (A) responded to a combination of T1 and T2 peptides as well as to P18 ITB. Donor 2 (B) responded to a pool of T1 and T2 peptides. Donors 3 (C) and 4 (D) responded to a pool of P18 MN/Pl8IIIB peptides or to P18 MN, respectively. Donor 5 (E) and 7 (G) showed specific cytolytic activity against a pool of Ti, T2, and Th4.1 peptides. Significant Ti-specific CTL activity was detected in the Tl-stimulated cultures from donor 6 (F). Although peptide-specific CTL responses were detected only after in vitro stimulation with the peptides, the reported activity does not appear to represent a primary in vitro response to the peptides, since no env-specific lysis was detected in PBMC from any of the individuals exposed to HIV-negative blood or healthy donors. A representative negative CTL assay on env-stimulated cultures of an individual exposed to an HIV uninfected sample is shown in Fig. 1 H. To investigate the HLA restriction of these responses, CTL activity of stimulated cultures were assayed against peptidepulsed HLA class I-mismatched targets in some individual cases (for example, donor 2) (Fig. 2 A. ) No HIV-specific cytolytic activity of env-stimulated cultures was observed against heterologous EBV-transformed mismatched targets pulsed with the stimulatory peptide. In addition, there was complete inhibition of env-specific lysis of autologous peptide-pulsed targets in the presence of the anti-class I monoclonal antibody (W6/32) (donor 4) (Fig. 2 B) (Fig. 3) . Thus, PBMC from the donor in Fig. 3 production in response to the env peptides was tested simultaneously with the CTL assays. All of the CTL responders (7/20, 35%) were T helper reactive to the HIV env peptides at least once during the course of the study (Table III) Table II , and in detail in Fig. 4 . In two of the cases (A and E) CTL responses appear to parallel the T helper (IL-2) responses. There was concordance between the two assays at both time points for the donor shown in Fig. 4 E, and at the first time and third time points for the donor shown in Fig. 4 F. For one time point in three of the donors (C, D, and F) and for two time points for one donor (B) at least 30% env-specific lysis was observed when the IL-2 stimulation index was less than three. Conversely, only one donor exhibited strong IL-2 responses to env when CTL activity was < 10% (C). These results demonstrate that CTL activity to HIV peptides can occur in the absence of T helper activity. Nevertheless, in seven of the CTL responders the HIV peptides recognized as T cytolytic epitopes were also recognized as T helper epitopes, in some cases at nonconcordant time points, which may reflect differences in the kinetics of CTL and T helper activity. It is also possible that some of the IL-2 was generated by virus-specific CD8+ class I restricted T cells (32) .
Env-specific T helper responses evaluated in a total of 28 HIV seronegative, PCR negative HCW with HIV exposures, indicated that 21 of them (75%) showed responses to two or more of the five peptides and in certain individuals these responses were observed more than 23 wk after exposure. Surprisingly, 24% (9/38) of HCW with HIV negative exposures exhibited responses to the peptides in contrast to 9% (3/33) in healthy blood donors (Table IV) , and < 3% in > 200 previous low risk seronegative controls (M. Clerici et al., unpublished observations) and the difference between the groups were statistically significant. It cannot be ruled out that some of the exposures to negative fluids were actually to fluids from HIV-infected individuals who had not yet seroconverted. In contrast to the IL-2 (T helper) data, no env-specific CTL activity was detected in either of the two control groups.
To further investigate the nature of the observed CTL re- with autologous Ti and P18 MN-pulsed PBMC, from an HIV exposed HCW (donor 6) 425 d after exposure (Fig. 5) . In addition, the CTL lysed autologous P18 MN-pulsed targets but not P18MN-pulsed allogeneic HLA class I mismatched targets, indicating that the cytotoxicity observed in this system is MHC restricted (C). It is also important to note that these CTL responses were T1 or P18 MN-specific (A and B), because no significant lysis was observed against other HIV env peptides. In contrast, we were unable to generate env-specific CTL lines by parallel culture, under the same conditions, using PBMC from two donors exposed to HIV-negative blood.
Discussion
In * Statistically significant differences between the individuals exposed to HIV+ and HIV-body fluids or unexposed blood donors, P = 0.0001 (Chi-square test). t Statistically significant differences between the HCW exposed to HIV-body fluids and unexposed blood donors, P = 0.0005 (Chi-square test).
of AIDS and a low CD4 count; and long-term nonprogressors (33) (34) (35) (36) , patients who appear to be healthy and have not exhibited a decline in CD4+ T cell numbers during several years of follow-up. Another potentially useful population to study are individuals who have no evidence of infection, despite multiple exposures to HIV. In contrast to the objective of the studies of survivors and non-progressors which is to investigate mechanisms of survival after infection, this latter population can be used in the search for a correlate of protective immunity against HIV infection. At least 10 publications have reported detecting T cell responses in seronegative individuals including gay men (15, 16) , discordant sexual couples (13, 18, 23), newborns of HIV-infected mothers (17, (19) (20) (21) and accidentally exposed HCW (22) . The present study extends the preliminary HCW report (22) , which tested T helper cell responses in eight exposed HCW and nine controls, to now include 28 HIV-exposed seronegative HCW and 38 controls, and importantly also tests for env-specific CTL, as well for T possibility that this mechanism explains our findings seems unlikely based on the fact that dendritic cells represent 1 to 2% of circulating peripheral blood mononuclear cells and the volume of blood transferred was very small. Two aspects of our data also suggest that we restimulated a recall response, rather than priming a CTL response from a previously naive population in vitro. First, specific CTL activity was observed only in env-stimulated cultures from HIV exposed individuals (7/20) and not in those exposed to HIV negative samples (0/20) or healthy blood donors (0/7). Second, a single round of peptide stimulation was sufficient to detect cytolytic activity from bulk cultures, suggesting the presence of HIVspecific CTL memory precursors in circulation in these individuals. In contrast, the in vitro primary response described required multiple stimulations (47, 48) . Furthermore, we were unable to demonstrate CTL activity from fresh PBMC. This contrasts with the observation that HIV-specific CTL against several HIV antigens can be detected in fresh PBMC from many HIV-infected individuals (7, 8, 50, 51) .
Several lines of evidence suggest that CTL are an important component of the immune response to HIV infection. HIVspecific CTL precursors are present at high frequency very early during infection, often detected before seroconversion (6) . During the subsequent prolonged asymptomatic phase of infection, HIV specific CD8 + MHC class I restricted CTL activity can be detected directly from peripheral blood in the absence of in vitro stimulation (7, 8, 50, 51 ) . Progression to AIDS is accompanied by an increase in virus replication and a loss of CD8 + HIV-specific CTL activity (6, 52) . The association of the CTL response with the initial acute loss of viremia (9) (54) . Further support for this possibility comes from a study demonstrating resistance to SIV challenge in macaques previously exposed intravenously to sub infectious doses of SIV (55). The host's prior immunological background might also influence the immune system's ability to handle unrelated heterologous viral infections, as recently reported in murine viral infections (56, 57) .
CTL responses were observed in the absence of simultaneous T helper reactivity to the env peptides, as measured by IL-2 production in response to the peptides. The apparent dichotomy between CTL and T helper reactivity is also in agreement with studies in which CTL responses could be induced in the absence of CD4' T cell help (58) , and with the observation of intact CD8 + CTL function in CD4-deficient knockout mice (59) . Furthermore, recent studies on IL-2 negative mice suggested that this factor is not essential for either NK cell and or CTL activation during viral infection of mice (60, 61) . It is very possible that T helper responses were present, with specificity for epitopes different from those that we tested.
Our finding of coincident env-specific T helper and CTL responses to the same peptides raises the possibility that we selected responses from individuals whose T cells responded to particular peptides for both helper and effector function, since the cultures were not supplemented with exogenous IL-2. Alternatively, some IL-2 could have been produced by CD8 + T cells, as was reported for murine T cell responses from mice infected with vaccinia virus (32) .
T helper responses were detected in a much higher proportion of HIV exposed HCW than CTL responses (75% versus 35%), which is consistent with promiscuous T cell recognition of the peptides in the contest of several MHC class II alleles (62) . T helper but not CTL responses were observed in 24% of the control group exposed to seronegative blood. This high "background" could be accounted for by the putative crossreactivity between HIV env and other antigens to which these individuals were previously exposed, particularly the alloantigens to which the control groups of HCW were exposed. This possibility is consistent with the reported homologies between HIV proteins and self antigens (63) (64) (65) (66) (67) (68) . However, since the fraction positive is significantly higher than in other control groups, it is possible that some of the fluids were infected even though the donor was seronegative (i.e., had not yet seroconverted).
The ability to generate HIV env-specific CD8+ cell lines more than one year after HIV exposure favors the possibility that low dose exposure to HIV might generate HIV-specific long-term memory CTL precursors that could protect against subsequent exposure to HIV, as has been reported in animal models of other viral infections (69) (70) (71) .
The demonstration of CTL responses along with the observation of T helper responses to HIV peptides in HIV exposed but uninfected health care workers indicate that in vivo priming of T helper and cytotoxic T lymphocytes can occur after single documented accidental occupational exposure to HIV, and raises the possibility that cell mediated immune mechanisms will be involved in the containment of HIV infection.
